Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12857/115840
Title: Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005
Authors: Brennan, Bernadette
De Salvo, Gian Luca 
Orbach, Daniel
De Paoli, Angela 
Kelsey, Anna
Mudry, Peter
Francotte, Nadine
Van Noesel, Max
Bisogno, Gianni 
Casanova, Michela
Ferrari, Andrea
Keywords: Malignant rhabdoid tumour;Paediatric;Prognostic factors;Prospective registry;Survival
Keywords Plus: KIDNEY
Mesh headings: Antineoplastic Combined Chemotherapy Protocols;Rhabdoid Tumor;Sarcoma
Secondary Mesh headings: Chemoradiotherapy, Adjuvant;Child;Child, Preschool;Cyclophosphamide;Disease-Free Survival;Doxorubicin;Female;Humans;Infant;Infant, Newborn;Male;Neoplasm Staging;Prospective Studies;Vincristine
Issue Date: 2016
Publisher: ELSEVIER SCI LTD
Journal: European journal of cancer (Oxford, England : 1990) 
Abstract: 
Extracranial malignant rhabdoid tumours (MRT) are rare lethal childhood cancers that often occur in infants and have a characteristic genetic mutation in the SMARCB1 gene. The European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) conducted a multinational prospective study of registered cases of extracranial MRT to test an intensive multimodal approach of treatment for children with newly diagnosed extracranial MRT.
URI: http://hdl.handle.net/20.500.12857/115840
ISSN: 09598049
DOI: 10.1016/j.ejca.2016.02.027
Appears in Collections:Articles

Show full item record

PubMed Central
Citations 50

8
Last Week
0
Last month
0
checked on Aug 7, 2021

SCOPUSTM   
Citations

19
checked on Sep 1, 2020

WEB OF SCIENCETM
Citations

30
checked on Dec 4, 2021

Page view(s) 20

1
checked on Dec 8, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.